Eli Lilly (LLY): FY25 Q3 earnings call, Oct 30, 2025

Thu, Oct 30Earnings callSpeaker-labelled transcriptEli Lilly

No Kalshi or Polymarket word markets were listed for Eli Lilly’s Oct 30, 2025 earnings call (FY25 Q3). The transcript is searchable below (quotes of at most 25 words).

Updated

Transcript

quotes of at most 25 words

Speaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.

3 matches for “LillyDirect”; 3 quoted, at least 25 words apart.

Geoffrey Meachamanalystqa

…think about commercial strategy, would you characterize it as more consumer-centric through LillyDirect? Or should we think about it as a more typical pharma launch…

Ilya Yuffacompanyqa

…But we're seeing significant more volume go through a direct-to-consumer platform with LillyDirect, which says a lot about, one, what consumers and patients as well…

Lucas Montarcecompanyqa

…if you take, for example, a good proxy that for me is LillyDirect we have been priced over the last maybe 6 months already at…

Agents: this page as TSV at /api/v1/appearances/eli-lilly:2025-10-30:earnings_call · words: /api/v1/brief?appearance=eli-lilly:2025-10-30:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP